Innovating Works

Novoptim

A stranger
FIDA: Scale up of our disruptive antibody analytical platform based in flow induced dispersion analysis F... NOVOPTIM SARL participó en un H2020: H2020-EIC-FTI-2018-2020 Therapeutic antibodies have rapidly become a major component of modern medicine. The global research antibodies market size is expected to r...
2019-11-05 - 2022-05-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.